NCT07087080View on ClinicalTrials.gov

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

April 1, 2027

Study Completion Date

November 1, 2027

Conditions
Solitary Pulmonary NodulesLung Cancer
Interventions
OTHER

Blood sampling

Single blood sampling (16 ml) after study inclusion before undergoing the PET-CT scan

Trial Locations (1)

3600

RECRUITING

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
collaborator

Ziekenhuis Oost-Limburg

OTHER

lead

Hasselt University

OTHER